Valuation Roche Holding AG

Stocks

Market Closed - Swiss Exchange Other stock markets 16:30:33 10/07/2026 BST			5-day change	1st Jan Change
336.60 ^CHF	+0.33%		-1.17%	+2.56%

07-09	Roche's Tuberculosis Test Receives CE Mark	MT
07-08	ABB Robotics Partners with Roche Diagnostics	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	268,274	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	2.36%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	278,830	272,193	264,558
Change	-	-21.41%	-15.51%	3.13%	25.04%	0.21%	-2.38%	-2.81%
P/E	23.4x	18.9x	17.1x	24.8x	20.5x	18x	16.7x	15.4x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.66x	5.62x	4.78x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.1x	2.25x	1.73x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.28x	4.11x	3.92x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.45x	4.17x	3.87x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	11x	10x	9.18x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12.4x	11.2x	10.3x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	17.9x	16.6x	15x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.57%	6.01%	6.68%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.01	10.25	10.53
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	2.97%	3.05%	3.13%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.72	20.11	21.9
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.5%	51%	48.1%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,644	65,275	68,382
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,332	27,129	28,830
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,555	24,198	25,739
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,217	16,319	17,533
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,556	3,919	-3,716
Reference price ²	379.10	290.50	244.50	255.50	328.20	336.60	336.60	336.60
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	03/02/22	02/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30x	7.34x	15.02x	2.76%	438B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.77x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.02x	5.6x	31.12x	2.5%	161B
PFIZER INC.	12.29x	3.03x	7.56x	7.14%	138B
Average	15.76x	6.10x	15.57x	2.91%	371.17B
Weighted average by Cap.	23.43x	7.67x	17.77x	2.19%